Osteopore Limited (OSX.AX)

AUD 0.04

(0.0%)

EBITDA Summary of Osteopore Limited

Osteopore Limited's latest annual EBITDA in 2023 was -4.34 Million AUD , down -12.48% from previous year.
Osteopore Limited's latest quarterly EBITDA in 2024 Q2 was -896.19 Thousand AUD , down 0.0% from previous quarter.
Osteopore Limited reported an annual EBITDA of -3.96 Million AUD in 2022, down -17.09% from previous year.
Osteopore Limited reported an annual EBITDA of -3.37 Million AUD in 2021, down -91.73% from previous year.
Osteopore Limited reported a quarterly EBITDA of -2.76 Million AUD for 2023 Q2, down -95.38% from previous quarter.
Osteopore Limited reported a quarterly EBITDA of N/A for 2023 FY, down -12.48% from previous quarter.

Annual EBITDA Chart of Osteopore Limited (2023 - 2016)

Historical Annual EBITDA of Osteopore Limited (2023 - 2016)

Year	EBITDA	EBITDA Growth
2023	-4.34 Million AUD	-12.48%
2022	-3.96 Million AUD	-17.09%
2021	-3.37 Million AUD	-91.73%
2020	-1.76 Million AUD	23.18%
2019	-2.29 Million AUD	-178.13%
2018	-793.16 Thousand AUD	-80.89%
2017	-374.09 Thousand AUD	54.93%
2016	-924.42 Thousand AUD	0.0%

Year	EBITDA	EBITDA Growth
2024 Q2	-896.19 Thousand AUD	0.0%
2023 Q2	-2.76 Million AUD	-95.38%
2023 FY	- AUD	-12.48%
2023 Q4	-1.57 Million AUD	-101.08%
2023 Q1	-1.41 Million AUD	34.59%
2023 Q3	-783.16 Thousand AUD	71.72%
2022 Q2	-1.87 Million AUD	-102.58%
2022 FY	- AUD	-17.09%
2022 Q4	-2.16 Million AUD	-100.56%
2022 Q3	-1.08 Million AUD	42.48%
2022 Q1	-927.17 Thousand AUD	58.39%
2021 Q2	-1.44 Million AUD	-130.88%
2021 FY	- AUD	-91.73%
2021 Q4	-2.22 Million AUD	-105.23%
2021 Q3	-1.08 Million AUD	24.73%
2021 Q1	-624.77 Thousand AUD	55.0%
2020 FY	- AUD	23.18%
2020 Q4	-1.38 Million AUD	-296.89%
2020 Q3	-349.83 Thousand AUD	68.15%
2020 Q2	-1.09 Million AUD	-100.29%
2020 Q1	-548.42 Thousand AUD	23.79%
2019 Q2	-434.62 Thousand AUD	0.06%
2019 FY	- AUD	-178.13%
2019 Q1	-434.88 Thousand AUD	0.0%
2019 Q4	-719.58 Thousand AUD	-1.51%
2019 Q3	-708.84 Thousand AUD	-63.1%
2018 FY	- AUD	-80.89%
2017 FY	- AUD	54.93%
2016 FY	- AUD	0.0%

Peer EBITDA Comparison of Osteopore Limited

Name	EBITDA	EBITDA Difference
Austco Healthcare Limited	8.11 Million AUD	153.599%
Nanosonics Limited	21.72 Million AUD	120.02%
SDI Limited	20.96 Million AUD	120.749%
Trajan Group Holdings Limited	-20.35 Million AUD	78.636%